Will the FDA publicly accept a multi-condition geroscience endpoint as sufficient to establish efficacy before 2036?
$575 volume
Will the FDA publicly accept a multi-condition geroscience endpoint as sufficient to establish efficacy before 2036?
57.6%$0.58
Loading chart...
Selected BetWill the FDA publicly accept a multi-condition geroscience endpoint as sufficient to establish efficacy before 2036?
M
Trading via ManifoldMarket Volume$575
Yes
No